InterACT Rx Pharmacodynamic Insights: A Brief Look at QTc Prolongation, Serotonin Syndrome, and Tardive Dyskinesia

Please join us for educational webinar hosted by Savannah Clary, Pharm.D., BCPS, Aegis Sciences Corporation. Dr. Clary will discuss medication classes that put patients at risk for these adverse drug effects, factors that may increase the risk or severity of adverse drug effects, and the role of InterACT Rx testing in helping identify interacting substances.

Objectives include:

• Define QTc Prolongation, Serotonin Syndrome, and Tardive Dyskinesia
• List examples of medication classes that put patients at risk for these adverse drug effects (ADEs)
• Describe factors that may increase the risk or severity of these ADEs 
• Understand the role of InterACT Rx testing in helping identify interacting substances capable of causing these ADEs